Bayesian Capital Management’s Envista NVST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,600
Closed -$379K 401
2025
Q3
$379K Sell
18,600
-45,600
-71% -$937K 0.08% 337
2025
Q2
$1.25M Buy
+64,200
New +$1.12M 0.2% 152
2025
Q1
Sell
-10,900
Closed -$210K 862
2024
Q4
$210K Sell
10,900
-26,200
-71% -$518K 0.03% 557
2024
Q3
$733K Buy
+37,100
New +$646K 0.09% 292
2023
Q2
Sell
-27,494
Closed -$1.12M 986
2023
Q1
$1.12M Sell
27,494
-6,600
-19% -$251K 0.14% 217
2022
Q4
$1.15M Buy
+34,094
New +$1.17M 0.17% 156
2022
Q2
Sell
-5,184
Closed -$253K 989
2022
Q1
$253K Buy
+5,184
New +$239K 0.04% 580
2021
Q3
Sell
-12,700
Closed -$549K 489
2021
Q2
$549K Buy
12,700
+2,061
+19% +$89.4K 0.14% 178
2021
Q1
$434K Buy
+10,639
New +$405K 0.1% 255

Other funds holding NVST

Bayesian Capital Management's NVST Position: Q4 2025 in Review

Bayesian Capital Management sold out of Envista (NVST) in Q4 2025, closing a stake of 18,600 shares — an estimated $379K sold.

Bayesian Capital Management first reported a position in NVST in Q1 2021 and held it in 9 quarters. The position peaked at $1.25M in Q2 2025. 337 funds tracked by Wall St. Rank hold NVST as of Q4 2025.

  • Bayesian Capital Management reported no remaining Envista position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 18,600 Envista shares in Q4 2025, an estimated $379K.
  • Bayesian Capital Management first reported a position in Envista in Q1 2021 and held it in 9 quarters.
  • Bayesian Capital Management's Envista position peaked at $1.25M in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Envista as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.